UNCY
Unicycive Therapeutics Inc. Common Stock
$0.638+0.000 (0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.638
High
$0.638
Low
$0.638
Volume
3.49M
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
- The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor - FDA to provide final decision by PDUFA action date of June 28, 2025 LOS ALTOS, Calif., June 10,
View more
Analyst Upgrades
HC Wainwright & Co. Assumes Unicycive Therapeutics at Buy, Announces Price Target of $9
HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Unicycive Therapeutics with a Buy rating and announces Price Target of $9.
View more
GlobeNewswire
Unicycive Therapeutics to Present at Upcoming Investor Conferences
LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.